Dawako Medtech — Seed (estimated)

BeAble Capital, a deep-science VC firm, invested in Dawako during 2024. It named the company as one of its new portfolio additions in its 2024 activity report, published 13 Feb 2025. Only the year is known, so the date is set to 2024-01. No amount, stage or co-investors were disclosed; databases also list INNVIERTE (CDTI) as an investor, but no source confirms it took part in this deal. Earlier, the company opened a €1.2M equity crowdfunding campaign on Capital Cell (Feb 2022) that was never reported as closed, and received a €770K public grant with Sabartech for a sarcopenia platform. Neither is filed as a round.